The global regenerative medicine market size was valued at USD xx billion in 2016 and it is expected to grow at a massive CAGR of xx% during the forecast period, reaching a market value of USD xx billion by the year 2025. From being able to identify and heal life threatening diseases, to their prevention, the health and medicine sector has witnessed a revolutionary development over the years, with regenerative medicine being a major innovation.
Several government organizations and private institutions are investing in the regenerative medicine industry, for research and development. New development is undertaken as per the rules and regulations standardized by organizations like Food and Drug Administration (FDA) in the USA, the European Medicines Agency (EMA) in Europe and other regional authorities.
The average life expectancy of a human being has increased, thus giving rise to the geriatric population. That, coupled with the increasing number of neurodegenerative, orthopedic, oncological, genetic and chronic disorders, constitutes the major factors that are fuelling the growth of the regenerative medicine market size. It has provided a tremendous opportunity to manufacturers, to satisfy this demand of the market. They are collaborating with leading research specialists, labs, pharmaceutical and biotechnology companies, and investors, towards the invention of more regenerative medicines, like gene therapy, nanotechnology, and tissue engineering. The regenerative medicine industry is evolving as one of the most cost-effective and definitive healthcare solutions. Regenerative medicine product analysis shows cell therapy fetching the highest revenue in the forecast period followed by tissue engineering, gene therapy and small molecules and biologics.
North America is expected to hold the highest regenerative medicine market share which invests in oncology and stem cell research. Presence of organizations such as National Cancer Institute, Alliance for Regenerative Medicine, National Institutes of Health and International Society for stem cell research supports the research and development of regenerative medicine which is accelerating the growth in this region. The Asia Pacific region is expected to witness the fastest growth during the forecast period, owing to the population growth in this region. Countries like China and Japan are introducing flexible regulations towards the clinical adoption of regenerative medicine techniques. The government is also actively participating in funding towards the infrastructure required for the research and development. Thus, boosting the global regenerative medicine market further.
• Tissue-engineered Products
• Cell Therapies
o Autologous Therapies
o Allogenic Therapies
• Gene Therapies
• Progenitor & Stem Cell Therapies
• Wound Care
• Other Applications
Regional Overview, 2018-2028 (USD Billion)
- North America
- Rest of Europe
- Asia Pacific
- Rest of Asia-Pacific
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
- South America
- Rest of South America
What to expect from the upcoming report on ‘Global Regenerative Medicine Market’:
- Growth projections of the global regenerative medicine market during the forecast period (2018-2025).
-Areas of growth and concern in the field of regenerative medicine.
- Economic factors likely to influence the market.
- Trends, drivers, opportunities, restraints, and challenges in the development and use of regenerative medicine.
- The involvement of government and other private organizations that are elevating the research and development of regenerative medicine.
- Analysis of the regional demographics affecting the market.
- Information about the competitors in the market, and the initiatives taken by them to improve this market.